Literature DB >> 12234253

Cloning and functional characterization of the human fractalkine receptor promoter regions.

Alexandre Garin1, Philippe Pellet, Philippe Deterre, Patrice Debré, Christophe Combadière.   

Abstract

We have previously shown that reduced expression of the fractalkine receptor, CX3CR1, is correlated with rapid HIV disease progression and with reduced susceptibility to acute coronary events. In order to elucidate the mechanisms underlying transcriptional regulation of CX3CR1 expression, we structurally and functionally characterized the CX3CR1 gene. It consists of four exons and three introns spanning over 18 kb. Three transcripts are produced by splicing the three untranslated exons with exon 4, which contains the complete open reading frame. The transcript predominantly found in leucocytes corresponds to the splicing of exon 2 with exon 4. Transcripts corresponding to splicing of exons 1 and 4 are less abundant in leucocytes and splicing of exons 3 and 4 are rare longer transcripts. A constitutive promoter activity was found in the regions extending upstream from untranslated exons 1 and 2. Interestingly, exons 1 and 2 enhanced the activity of their respective promoters in a cell-specific manner. These data show that the CX3CR1 gene is controlled by three distinct promoter regions, which are regulated by their respective untranslated exons and that lead to the transcription of three mature messengers. This highly complex regulation may allow versatile and precise expression of CX3CR1 in various cell types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234253      PMCID: PMC1223041          DOI: 10.1042/BJ20020951

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa.

Authors:  A Muehlhoefer; L J Saubermann; X Gu; K Luedtke-Heckenkamp; R Xavier; R S Blumberg; D K Podolsky; R P MacDermott; H C Reinecker
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

2.  The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.

Authors:  A D Lucas; N Chadwick; B F Warren; D P Jewell; S Gordon; F Powrie; D R Greaves
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.

Authors:  S Jung; J Aliberti; P Graemmel; M J Sunshine; G W Kreutzberg; A Sher; D R Littman
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1.

Authors:  S Faure; L Meyer; D Costagliola; C Vaneensberghe; E Genin; B Autran; J F Delfraissy; D H McDermott; P M Murphy; P Debré; I Théodorou; C Combadière
Journal:  Science       Date:  2000-03-24       Impact factor: 47.728

5.  Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.

Authors:  D Moatti; S Faure; F Fumeron; M el-W Amara; P Seknadji; D H McDermott; P Debré; M C Aumont; P M Murphy; D de Prost; C Combadière
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

6.  Analysis of the CC chemokine receptor 3 gene reveals a complex 5' exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elements.

Authors:  N Zimmermann; B L Daugherty; J L Kavanaugh; F Y El-Awar; E A Moulton; M E Rothenberg
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

7.  Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human.

Authors:  A Foussat; A Coulomb-L'Hermine; J Gosling; R Krzysiek; I Durand-Gasselin; T Schall; A Balian; Y Richard; P Galanaud; D Emilie
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

8.  Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival.

Authors:  O Meucci; A Fatatis; A A Simen; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

9.  The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia.

Authors:  S A Boehme; F M Lio; D Maciejewski-Lenoir; K B Bacon; P J Conlon
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

10.  Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia.

Authors:  J K Harrison; Y Jiang; S Chen; Y Xia; D Maciejewski; R K McNamara; W J Streit; M N Salafranca; S Adhikari; D A Thompson; P Botti; K B Bacon; L Feng
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

View more
  9 in total

1.  CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung.

Authors:  Cyrille Mionnet; Vanessa Buatois; Akira Kanda; Valerie Milcent; Sebastien Fleury; David Lair; Marie Langelot; Yannick Lacoeuille; Edith Hessel; Robert Coffman; Antoine Magnan; David Dombrowicz; Nicolas Glaichenhaus; Valerie Julia
Journal:  Nat Med       Date:  2010-10-31       Impact factor: 53.440

2.  DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine.

Authors:  Min Sun Shin; Sungyong You; Youna Kang; Naeun Lee; Seung-Ah Yoo; Kieyoung Park; Ki Soo Kang; Sang Hyun Kim; Subhasis Mohanty; Albert C Shaw; Ruth R Montgomery; Daehee Hwang; Insoo Kang
Journal:  J Immunol       Date:  2015-08-14       Impact factor: 5.422

3.  Evolution of the ability to modulate host chemokine networks via gene duplication in human cytomegalovirus (HCMV).

Authors:  Jessica A Scarborough; John R Paul; Juliet V Spencer
Journal:  Infect Genet Evol       Date:  2017-03-14       Impact factor: 3.342

4.  Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma.

Authors:  Po-Jui Chang; Pankaj K Bhavsar; Charalambos Michaeloudes; Nadia Khorasani; Kian Fan Chung
Journal:  J Allergy Clin Immunol       Date:  2012-09-01       Impact factor: 10.793

Review 5.  Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.

Authors:  Łukasz A Poniatowski; Piotr Wojdasiewicz; Maciej Krawczyk; Dariusz Szukiewicz; Robert Gasik; Łukasz Kubaszewski; Iwona Kurkowska-Jastrzębska
Journal:  Mol Neurobiol       Date:  2016-03-01       Impact factor: 5.590

6.  Fractalkine Regulates HEC-1A/JEG-3 Interaction by Influencing the Expression of Implantation-Related Genes in an In Vitro Co-Culture Model.

Authors:  Ramóna Pap; Gergely Montskó; Gergely Jánosa; Katalin Sipos; Gábor L Kovács; Edina Pandur
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

7.  Rosiglitazone activation of PPARgamma suppresses fractalkine signaling.

Authors:  Yihong Wan; Ronald M Evans
Journal:  J Mol Endocrinol       Date:  2009-10-22       Impact factor: 5.098

8.  Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene.

Authors:  Tiansuo Zhao; Song Gao; Xiuchao Wang; Jingcheng Liu; Yitao Duan; Zhanna Yuan; Jun Sheng; Shasha Li; Feng Wang; Ming Yu; He Ren; Jihui Hao
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

9.  Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection.

Authors:  M Parczewski; M Leszczyszyn-Pynka; M Kaczmarczyk; G Adler; A Binczak-Kuleta; B Loniewska; A Boron-Kaczmarska; A Ciechanowicz
Journal:  J Appl Genet       Date:  2009       Impact factor: 2.653

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.